<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rapid sequence induction and intubation (RSII) for anesthesia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rapid sequence induction and intubation (RSII) for anesthesia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Rapid sequence induction and intubation (RSII) for anesthesia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lauren C Berkow, MD, FASA</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carin A Hagberg, MD, FASA</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marianna Crowley, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 05, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1078268993"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Rapid sequence induction and intubation (RSII) for anesthesia is a technique designed to minimize the chance of pulmonary aspiration in patients who are at higher than normal risk. The usual, nonrapid sequence of induction and intubation for anesthesia consists of administration of an induction agent, proof of the ability to mask ventilate, administration of a neuromuscular blocking agent (NMBA), and endotracheal intubation once paralysis is achieved, usually approximately three minutes after induction. Since induction of anesthesia results in loss of airway protective reflexes, pulmonary aspiration is a risk during the interval between loss of consciousness and inflation of the cuff of the endotracheal tube.</p><p>The components of RSII are designed to protect the airway with a cuffed endotracheal tube as quickly as possible after induction, while reducing the chance of passive or active regurgitation. An essential goal of RSII is the achievement of adequate depth of anesthesia, and, most often, paralysis, for laryngoscopy, to prevent coughing, straining, and active vomiting with airway manipulation.</p><p>While RSII is a departure from the usual practice of induction of anesthesia, the equivalent method of rapid airway control, often called "rapid sequence intubation" (RSI), is the most commonly used method of controlling the airway in the emergency department.</p><p>This topic will discuss the components, techniques, and medications used for RSII for anesthesia. Preoperative fasting guidelines, airway management for induction of anesthesia, RSI in the emergency department, and medications used for induction of anesthesia are discussed more fully separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15698.html" rel="external">"Preoperative fasting in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p></p><p class="headingAnchor" id="H1078268999"><span class="h1">INDICATIONS</span></p><p class="headingAnchor" id="H211963066"><span class="h2">General indications</span><span class="headingEndMark"> — </span>RSII should be considered for the patient who is at increased risk of aspiration with induction of anesthesia. This includes the patient with a full stomach, gastrointestinal pathology, increased abdominal pressure, or pregnancy after 20 weeks gestation  (<a class="graphic graphic_table graphicRef98506" href="/d/graphic/98506.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with a full stomach, which includes:</p><p class="bulletIndent2"><span class="glyph">•</span>Patients undergoing emergency surgery</p><p class="bulletIndent2"><span class="glyph">•</span>Patients who have sustained trauma, regardless of the interval since last oral intake</p><p class="bulletIndent2"><span class="glyph">•</span>Patients who have not fasted according to preoperative fasting guidelines (see  <a class="medical medical_review" href="/d/html/15698.html" rel="external">"Preoperative fasting in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with gastrointestinal pathology, which includes:</p><p class="bulletIndent2"><span class="glyph">•</span>Gastroparesis or delayed gastric emptying (eg, due to diabetic autonomic neuropathy, patients taking glucagon-like peptide-1 [GLP-1] receptor agonists)</p><p class="bulletIndent2"><span class="glyph">•</span>Small bowel obstruction</p><p class="bulletIndent2"><span class="glyph">•</span>Gastric outlet obstruction</p><p class="bulletIndent2"><span class="glyph">•</span>Esophageal stricture</p><p class="bulletIndent2"><span class="glyph">•</span>Gastroesophageal reflux disease (see <a class="local">'Gastroesophageal reflux disease (GERD)'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with increased intraabdominal pressure, which includes those with:</p><p class="bulletIndent2"><span class="glyph">•</span>Morbid obesity</p><p class="bulletIndent2"><span class="glyph">•</span>Ascites</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy after 20 weeks gestation; earlier if symptoms of gastroesophageal reflux (controversial) (see  <a class="medical medical_review" href="/d/html/6775.html" rel="external">"Anesthesia for nonobstetric surgery during pregnancy", section on 'Preoperative aspiration mitigation'</a>)</p><p></p><p class="headingAnchor" id="H58982"><span class="h2">Gastroesophageal reflux disease (GERD)</span><span class="headingEndMark"> — </span>GERD is a common condition that may put patients at risk for passive regurgitation and subsequent aspiration during induction of anesthesia.</p><p class="headingAnchor" id="H211963099"><span class="h3">Patient selection</span><span class="headingEndMark"> — </span>The decision to perform RSII for patients with GERD must be individualized based on the degree of symptoms and the potential risk of RSII. Patients should be questioned about symptoms of reflux during preoperative evaluation, including the presence of heartburn, regurgitation, dysphagia, reflux symptoms at night, and the need to sleep with the head of the bed elevated to avoid reflux. We consider RSII for the following patients:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with current symptoms of active reflux (ie, regurgitation, heartburn, or the need to sleep with the head of the bed elevated)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who had significant symptoms of active reflux prior to starting antacid medication, such as proton pump inhibitor (PPI), histamine-2 receptor antagonist (H2RA), or <a class="drug drug_general" data-topicid="9185" href="/d/drug information/9185.html" rel="external">calcium carbonate</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who believe that symptoms of reflux would recur if antacid therapy was discontinued</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with hiatal hernia or endoscopic evidence of GERD</p><p></p><p>We do not routinely perform RSII for patients who report heartburn only with spicy or acidic foods.</p><p>Clinical manifestations, diagnosis, and management of GERD are discussed more fully separately. (See  <a class="medical medical_review" href="/d/html/5892.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents"</a> and  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults"</a>.)</p><p class="headingAnchor" id="H107497733"><span class="h3">Preoperative antacids</span><span class="headingEndMark"> — </span>Patients presenting for elective surgery who take antacid medication, including PPIs and H2RAs, on a regular or as-needed basis should be instructed to take their usual medication before surgery. PPIs are more effective at reducing gastric volume and increasing pH if given in two doses, one the evening prior to surgery, and another on the morning of surgery [<a href="#rid1">1,2</a>]. A single dose of oral <a class="drug drug_general" data-topicid="9853" href="/d/drug information/9853.html" rel="external">ranitidine</a> three hours prior to induction of anesthesia has been shown to significantly reduce gastric volume and increase pH of stomach contents. Ranitidine is no longer available in the United States. Alternatives include <a class="drug drug_general" data-topicid="8436" href="/d/drug information/8436.html" rel="external">famotidine</a>, <a class="drug drug_general" data-topicid="9265" href="/d/drug information/9265.html" rel="external">cimetidine</a>, or a PPI. When administered orally, two doses of a PPI are required for maximum efficacy (one the evening before and one the morning of surgery). A meta-analysis of randomized trials that compared efficacy of H2RAs with PPIs found that a single IV dose or two oral doses of PPIs were as effective as H2RAs administered by either route [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H628740622"><span class="h2">Patients taking GLP-1 receptor agonists</span><span class="headingEndMark"> — </span>Delayed gastric emptying is a potential side effect of GLP-1 receptor agonists (eg, <a class="drug drug_general" data-topicid="115980" href="/d/drug information/115980.html" rel="external">semaglutide</a>, <a class="drug drug_general" data-topicid="9522" href="/d/drug information/9522.html" rel="external">liraglutide</a>), which are used to treat diabetes and are increasingly used for weight loss. Patients who take these medications may have residual gastric contents despite preoperative fasting [<a href="#rid4">4-6</a>] and may be at increased risk of aspiration during induction of anesthesia.</p><p>In 2023, the American Society of Anesthesiologists (ASA) issued guidance on preoperative management of patients taking GLP-1 agonists based on some case reports of aspiration during anesthesia [<a href="#rid4">4,5,7,8</a>]. The ASA recommends holding the daily or weekly dose of GLP-1 agonists prior to elective surgery and, for patients who take the drug up until the day of surgery, performing RSII. For patients with diabetes, glucose management may require coordination with the prescribing clinician when the GLP-1 agonist is held.</p><p>Gastrointestinal side effects (nausea, vomiting, diarrhea) are common with GLP-1 agonists, particularly early in treatment. (See  <a class="medical medical_review" href="/d/html/1772.html" rel="external">"Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus", section on 'Gastrointestinal'</a> and  <a class="medical medical_review" href="/d/html/5376.html" rel="external">"Obesity in adults: Drug therapy", section on 'GLP-1 receptor agonists'</a>.)</p><p>The literature on the effect of GLP-1 agonists on gastric emptying is inconclusive. Several observational studies have found increased risk of residual gastric contents at the time of upper gastrointestinal endoscopy in patients taking GLP-1 receptor agonists for diabetes or for weight loss [<a href="#rid4">4,5,9,10</a>]. By contrast, several studies using paracetamol absorption to assess gastric emptying found no effect of <a class="drug drug_general" data-topicid="115980" href="/d/drug information/115980.html" rel="external">semaglutide</a> after the first few hours after a dose [<a href="#rid11">11-13</a>].</p><p>In patients presenting for surgery who have not held their GLP-1 receptor agonists for one week or more, gastric ultrasound can be considered to assess for the presence of gastric contents and to guide the need for rapid sequence intubation (RSI). If gastric ultrasound is not available or inconclusive, it is reasonable to perform RSII to minimize aspiration risk.</p><p class="headingAnchor" id="H73917"><span class="h1">PREPARATION FOR ANESTHESIA</span><span class="headingEndMark"> — </span>In addition to the preparation for routine induction of anesthesia, an assistant should be present who understands RSII and is capable of correctly applying cricoid pressure to assist in airway management.</p><p class="headingAnchor" id="H73938"><span class="h2">Airway evaluation</span><span class="headingEndMark"> — </span>Airway evaluation is an important step in making the decision to perform an RSII. If a difficult airway is predicted, the risk of aspiration must be weighed against the risk of difficult or failed airway management. This is because RSII usually includes the administration of a neuromuscular blocking agent (NMBA) without proof that mask ventilation will be possible once the patient is paralyzed. In all but the most urgent situations, a quick airway examination and query about previous airway problems should be possible. If difficult airway management is expected, a modified RSII, awake intubation, or even an inhalation induction may be chosen as alternatives. The 2022 American Society of Anesthesiologists (ASA) Difficult Airway Guidelines recommend an awake intubation strategy when both difficult intubation and a significant risk of aspiration are present  (<a class="graphic graphic_algorithm graphicRef134460" href="/d/graphic/134460.html" rel="external">algorithm 1</a> and <a class="graphic graphic_figure graphicRef135096" href="/d/graphic/135096.html" rel="external">figure 1</a>) [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia", section on 'Prediction of the difficult airway'</a> and <a class="local">'Potential complications of RSII'</a> below.)</p><p class="headingAnchor" id="H73932"><span class="h2">Equipment</span><span class="headingEndMark"> — </span>Preparation of equipment for RSII should be similar to that for routine induction. An assortment of standard and alternative airway devices should be immediately available, including small, medium, and large facemasks; several sizes and types of laryngoscopes; oral and nasal airways; several sizes of supraglottic airway, and a bougie. Alternative devices for laryngoscopy, including a video laryngoscope and flexible intubating scope, as well as other emergency airway equipment, should be accessible quickly and present in the operating room or anesthetizing location if difficult airway is suspected. Working suction must always be close by during induction of anesthesia; for RSII, we usually place the suction directly under the headrest for immediate access.</p><p class="headingAnchor" id="H61805"><span class="h2">Premedication</span><span class="headingEndMark"> — </span>Premedication may be administered prior to RSII to relieve anxiety, to blunt or eliminate the physiologic response to airway management, and to reduce the volume or increase the pH of stomach contents.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anxiolytics </strong>– For patients who are hemodynamically stable, a benzodiazepine (eg, <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> up to 1 to 2 mg IV) may be administered to reduce anxiety. This dose should be titrated cautiously in older adults and when given simultaneously with narcotic premedication, to avoid hypotension and loss of protective airway reflexes [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atropine</strong><strong> </strong>– The administration of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> and airway manipulation can trigger a vagal response, especially in children and neonates. We therefore suggest the use of <a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">atropine</a> with RSII for all children younger than one year and for children less than five years of age who receive succinylcholine, though succinylcholine is rarely administered to children in the operating room. (See  <a class="medical medical_review" href="/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach", section on 'Pretreatment'</a>.)</p><p></p><p class="bulletIndent1">A vagal response to straightforward endotracheal intubation is much less common in adults; as such, <a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">atropine</a> is not routinely administered as a premedication before RSII for adults. However, anticholinergic treatment may be required if bradycardia occurs with difficult laryngoscopy and intubation, or as a result of intubation in patients with preexisting bradycardia caused by medication or conduction system disease [<a href="#rid16">16-18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Opioids </strong>– Opioids may be administered as part of premedication for analgesia and sedation. They should be titrated to avoid respiratory depression and loss of protective airway reflexes in patients at risk for aspiration, especially in older patients, and when administered with benzodiazepines.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antacids </strong>– We suggest premedication with antacids prior to induction of anesthesia for patients at high risk of aspiration to increase the pH of gastric contents so that, if aspiration does occur, it will result in less pulmonary damage. Several classes of antacid medication are routinely used:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clear, nonparticulate oral antacid (eg, <a class="drug drug_general" data-topicid="9930" href="/d/drug information/9930.html" rel="external">sodium citrate-citric acid</a>, 30 mL orally immediately prior to induction) increases pH of stomach contents [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Histamine-2 receptor antagonist (H2RA) (eg, <a class="drug drug_general" data-topicid="8436" href="/d/drug information/8436.html" rel="external">famotidine</a> 20 mg IV, given 40 to 60 minutes prior to induction) reduces the volume and increases the pH of stomach contents.</p><p></p><p class="bulletIndent1">For pregnant patients and for those at high risk of aspiration, we routinely administer clear, nonparticulate antacid prior to induction. For nonpregnant patients at high risk of aspiration who have not received a proton pump inhibitor (PPI) or H2RA on the morning of surgery, we also administer an H2RA 40 to 60 minutes prior to induction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prokinetic agent </strong>–<strong> </strong>Intravenous (IV) <a class="drug drug_general" data-topicid="9642" href="/d/drug information/9642.html" rel="external">metoclopramide</a> increases lower esophageal sphincter tone [<a href="#rid20">20</a>], induces peristalsis, and enhances stomach emptying, thereby reducing gastric volume and the risk of regurgitation. Metoclopramide is particularly useful in patients with gastroparesis undergoing general anesthesia. It is also antiemetic and may help prevent postoperative nausea and vomiting. Rare adverse effects of metoclopramide include extrapyramidal effects and tardive dyskinesia, which are more common if administered quickly. We reserve metoclopramide for patients with uncontrolled reflux and pregnant patients who are symptomatic with reflux. In this setting, we administer metoclopramide 10 mg IV over one to two minutes.</p><p></p><p class="headingAnchor" id="H73981"><span class="h2">Positioning</span><span class="headingEndMark"> — </span>The patient's head should be positioned in the sniffing position to facilitate intubation (atlanto-occipital extension with head elevation of 3 to 7 cm). Obese patients may require a ramped position  (<a class="graphic graphic_figure graphicRef95285" href="/d/graphic/95285.html" rel="external">figure 2</a>). (See  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia", section on 'Patient positioning'</a>.)</p><p>When RSII is planned, we prefer to position the operating table with the head up because passive regurgitation and aspiration may be less likely if the larynx is above the level of the lower esophageal sphincter. We flex the operating table at the level of the patient's hips to elevate the back of the operating table, or tilt the table 20 degrees head up, making sure that once that is done, the height of the patient's head is optimal for intubation. Should the patient regurgitate prior to or during induction, the table should be quickly tipped head down, the patient's head turned to the side, and the mouth suctioned to avoid aspiration.</p><p>The optimal positioning for RSII remains controversial with a lack of scientific evidence to support a particular position. A simulation study in manikins found that the head-down position with neck extension reduced aspiration but made laryngoscopy more difficult [<a href="#rid21">21</a>].</p><p>Clinical recommendations and clinical practice patterns favor the head-up position [<a href="#rid22">22</a>]. Two 2020 surveys of clinician practice demonstrated a strong preference for the head-up position (60 to 70 percent) [<a href="#rid23">23,24</a>].</p><p class="headingAnchor" id="H74006"><span class="h2">Preoxygenation</span><span class="headingEndMark"> — </span>All patients presenting for general anesthesia should be preoxygenated with 100 percent oxygen to increase oxygen reserve and provide additional time to secure the airway. This is particularly important prior to RSII, since with this technique, mask ventilation is not usually performed between induction and intubation. Preoxygenation is administered for three minutes of normal tidal volume breathing, for eight deep breaths over one minute, or until the fraction of expired oxygen is over 90 percent [<a href="#rid25">25</a>]. (See <a class="local">'Mask ventilation'</a> below.)</p><p>The use of nasal cannula for passive apneic oxygenation during laryngoscopy can prolong the time to desaturation in high-risk patients during airway management [<a href="#rid26">26-28</a>]. We suggest the administration of oxygen by nasal cannula at 10 L in addition to facemask oxygen for those patients who are at high risk for rapid oxygen desaturation during the apneic period between induction and intubation, and for those at higher risk of difficult intubation.</p><p>The 2022 ASA Difficult Airway Guidelines recommend properly positioning the patient, administering supplemental oxygen before initiating management of the difficult airway and continuing to deliver supplemental oxygen whenever feasible throughout the process of difficult airway management, including extubation [<a href="#rid14">14</a>].</p><p>Methods for apneic oxygenation have become available that may be useful for preoxygenation as well as passive oxygenation during RSII. The transnasal humidified rapid insufflation ventilatory exchange (THRIVE) technique uses a device that provides humidified high-flow nasal oxygen with continuous positive airway pressure (CPAP). THRIVE may maintain a blood gas profile equivalent to face mask preoxygenation despite longer apnea time [<a href="#rid29">29,30</a>]. (See  <a class="medical medical_review" href="/d/html/113243.html" rel="external">"Preoxygenation and apneic oxygenation for airway management for anesthesia"</a>.)</p><p>A number of studies have shown either more rapid or effective preoxygenation or increased time to desaturation after apnea with the use of CPAP during preoxygenation [<a href="#rid31">31-33</a>]. CPAP can be provided using a tight-fitting anesthesia face mask, and pressure support ventilation provided with positive end-expiratory pressure (PEEP). Morbidly obese patients in particular may benefit from CPAP preoxygenation. Low levels of inspiratory pressure should be used to avoid gastric insufflation.</p><p class="headingAnchor" id="H74035"><span class="h1">CRICOID PRESSURE DURING RSII</span><span class="headingEndMark"> — </span>Although controversial, we routinely apply cricoid pressure (also known as Sellick's maneuver) prior to and during RSII until confirmation of correct endotracheal tube placement. Despite conflicting evidence regarding the effectiveness of cricoid pressure for preventing regurgitation, clinical experience suggests that, in most situations, it is not harmful and may be beneficial.</p><p>The most significant downside to the use of cricoid pressure is the possibility that it may make laryngoscopy, supraglottic airway placement, or mask ventilation more difficult. We routinely have an assistant apply cricoid pressure during RSII, but we communicate the need to shift or release the pressure, as necessary, to facilitate tracheal intubation. Cricoid pressure may have to be released if intubation proves difficult and/or mask ventilation, supraglottic airway placement, or flexible fiberoptic bronchoscopy become necessary. Indeed, the 2015 Difficult Airway Society guidelines from the United Kingdom recommend that cricoid pressure be released if initial attempts at laryngoscopy are difficult [<a href="#rid34">34</a>]. Should active vomiting occur, cricoid pressure should be released to avoid esophageal rupture.</p><p>We do not routinely use cricoid pressure during RSII for patients with acute cervical spinal cord injury because it can move unstable cervical spine fractures. In trauma patients with possible but unevaluated cervical spine injury, cricoid pressure should only be used along with manual in line stabilization to stabilize the posterior cervical spine. (See  <a class="medical medical_review" href="/d/html/91915.html" rel="external">"Anesthesia for adults with acute spinal cord injury", section on 'Airway management strategy'</a>.)</p><p>As originally described by Sellick in 1961, the cricoid cartilage ring is pressed backward by an assistant against the underlying cervical vertebrae, occluding the lumen of the esophagus to prevent regurgitation of stomach contents into the pharynx  (<a class="graphic graphic_figure graphicRef71800" href="/d/graphic/71800.html" rel="external">figure 3</a>) [<a href="#rid35">35</a>]. Based on cadaver and patient studies, pressure should be applied at 10 Newtons (approximately 2.5 lbs) while the patient is awake and increased to 30 Newtons after loss of consciousness. Despite these recommendations, clinicians and assistants are not routinely trained to standardize application of pressure [<a href="#rid36">36-38</a>].</p><p>While optimal external laryngeal manipulation (OELM) of the thyroid cartilage is often used to improve the view of the vocal cords during laryngoscopy, cricoid pressure should not be applied in an attempt to improve laryngeal view, as it may in fact make the view worse.</p><p class="headingAnchor" id="H1456685670"><span class="h2">Cricoid pressure controversies</span><span class="headingEndMark"> — </span>The need for, efficacy, anatomical basis, and optimal technique for application of cricoid pressure have all been questioned, and literature is inconclusive [<a href="#rid39">39</a>]. Some guidelines, including the American Heart Association Guidelines for Cardiopulmonary Resuscitation, no longer recommend the routine use of cricoid pressure [<a href="#rid40">40</a>].</p><p>A 2021 meta-analysis of five trials that assessed the impact of cricoid pressure on intubation outcomes in the operating room setting found a slightly higher time to intubation and incidence of hoarseness with the use of cricoid pressure, but no difference in first pass success rate or laryngoscopic view [<a href="#rid41">41</a>]. Only two randomized controlled trials have evaluated cricoid pressure for RSII with direct laryngoscopy [<a href="#rid42">42</a>]. In one of these trials the primary outcome was the pressor response to endotracheal intubation; there was no difference between patients who had cricoid pressure applied and those who did not [<a href="#rid43">43</a>]. The other trial, which evaluated aspiration and intubating conditions with and without cricoid pressure, was a prospective, randomized, multicenter study of 3472 patients who required RSII for increased risk of aspiration [<a href="#rid44">44</a>]. The incidence of aspiration was similar in the two groups (0.6 percent with cricoid pressure versus 0.5 percent without). Median intubation time was longer in patients who had cricoid pressure applied (27 versus 23 seconds), and there was higher incidence of Cormack Lehane grade 3 or 4 laryngeal views with cricoid pressure (10 versus 5 percent)  (<a class="graphic graphic_figure graphicRef141367" href="/d/graphic/141367.html" rel="external">figure 4</a>). (See  <a class="medical medical_review" href="/d/html/260.html" rel="external">"Direct laryngoscopy and endotracheal intubation in adults", section on 'Glottic view scores'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Evidence that cricoid pressure may reduce the incidence of aspiration of gastric contents is scant and consists primarily of observational clinical studies and experimental data from cadaver studies [<a href="#rid45">45</a>], including the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cadaver studies have shown that cricoid pressure prevents reflux of <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> into the pharynx at esophageal pressures up to 50 cmH<sub>2</sub>O [<a href="#rid36">36,46-48</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Several studies have shown that cricoid pressure prevents gastric insufflation during mask ventilation in children and adults [<a href="#rid49">49-51</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An observational study performed in patients undergoing elective surgery reported that cricoid pressure applied at 30 Newtons effectively occluded the upper esophagus, as determined by the inability to pass gastric tubes of two different sizes [<a href="#rid52">52</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There are case reports of regurgitation when cricoid pressure was released [<a href="#rid35">35,53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lack of efficacy of cricoid pressure and possible harm are suggested by several studies and observations, as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The anatomical basis for the use of cricoid pressure has been questioned by imaging studies. Both computed tomography (CT) and magnetic resonance imaging (MRI) studies have shown that the esophagus is located lateral to the midline in approximately 50 percent of patients [<a href="#rid54">54,55</a>]. The application of cricoid pressure displaced the esophagus laterally in 90 percent of subjects [<a href="#rid55">55</a>], suggesting that the esophagus would not be occluded by pressing the cartilage against cervical vertebrae. In contrast, an MRI study showed that application of 2 to 4 kg of cricoid pressure moved the cricoid cartilage and the hypopharynx as one unit, effectively obliterating the lumen of the alimentary tract, even with lateral displacement [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cricoid pressure at 20 Newtons has been shown to reduce lower esophageal pressure in awake, un-anesthetized volunteers (presumably by reflex), with restoration to baseline after release of pressure [<a href="#rid57">57</a>]. If applicable to anesthetized patients, this effect could theoretically increase the chance of gastroesophageal reflux, though it isn't clear whether this would increase the chance of reflux into the pharynx. Another study of awake volunteers reported that application of cricoid pressure did not promote gastroesophageal reflux [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Several studies have reported a worsened Cormack Lehane grade view during laryngoscopy, prolonged time to intubation, and/or airway obstruction with the use of cricoid pressure [<a href="#rid45">45,59-63</a>].</p><p></p><p class="headingAnchor" id="H64653824"><span class="h1">NASOGASTRIC TUBE</span><span class="headingEndMark"> — </span>For patients with bowel obstruction, ileus, and other gastrointestinal pathology, some clinicians place a nasogastric tube to decompress the stomach prior to induction of anesthesia. Nasogastric drainage or suction does not guarantee an empty stomach and may not remove particulate matter. Such patients often present for anesthesia and surgery with a nasogastric tube already in place. We generally leave the nasogastric tube in place during RSII, connect it to suction to drain the stomach prior to induction, and then leave it open to air as a vent for the stomach. The stomach is suctioned again prior to emergence. While presence of a nasogastric tube may impair the function of the lower and upper esophageal sphincters [<a href="#rid64">64</a>], two cadaver studies have shown that cricoid pressure effectively prevents regurgitation of stomach contents with a nasogastric tube in place [<a href="#rid37">37,46</a>]. In addition, the nasogastric tube can help identify the esophagus during laryngoscopy and therefore make esophageal intubation less likely.</p><p class="headingAnchor" id="H1078269017"><span class="h1">CHOICE OF MEDICATIONS</span><span class="headingEndMark"> — </span>Since the aim of RSII is to place an endotracheal tube as quickly as possible after loss of consciousness, all medications used should be rapid in onset, without significant hemodynamic effects when given at the required doses, and should achieve optimal intubating conditions. Depending on the planned surgical procedure, a short duration of action or reversibility may be desirable as well. An important goal of RSII is the achievement of an adequate depth of anesthesia and, in most cases, paralysis to prevent coughing, gagging, straining, or vomiting during airway manipulation.</p><p class="headingAnchor" id="H1078269059"><span class="h2">Induction agents</span></p><p class="headingAnchor" id="H107498165"><span class="h3">Dose and timing of induction agent</span><span class="headingEndMark"> — </span>We typically titrate the anesthesia induction agent to loss of consciousness prior to the administration of neuromuscular blocking agent (NMBA). As RSII was originally described, a precalculated dose of an induction drug was administered, immediately followed by an NMBA. This timing can result in either underdosing, with the possibility of awareness or an undesirable sympathetic response to intubation, or to overdosing, with the possibility of hypotension. An alternative method of administration is to titrate the induction medication to loss of consciousness, recognizing that total induction time may be slightly longer with a titration technique. There are no data comparing the risk of aspiration, awareness, or hemodynamic consequence of RSII using the titration versus bolus technique.</p><p class="headingAnchor" id="H64654732"><span class="h3">Choice of agent</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> is the induction agent we use most commonly for RSII, but the choice, dose, and speed of administration of the induction agent should be individualized. Patients presenting for emergency surgery may be hypovolemic or have other comorbidities that increase the risk of hemodynamic instability with induction. <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">Ketamine</a> and <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> are alternatives to propofol for patients at increased risk of hypotension with induction. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents"</a>.)</p><p class="headingAnchor" id="H1078269067"><span class="h3">Propofol</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> is the most commonly used medication for induction of anesthesia and for RSII. Advantages for RSII include its rapid onset (30 to 45 seconds) and its ability to suppress airway reflexes and produce apnea [<a href="#rid65">65</a>]. Duration of action of propofol is short (5 to 10 minutes), which is an advantage if airway management is difficult and the patient must be awakened. However, the short duration of action means that repeat doses of propofol may be required if airway management is prolonged. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Propofol'</a>.)</p><p><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> can cause hypotension because of dose-dependent venodilation, arterial dilation, and decrease in cardiac contractility [<a href="#rid66">66</a>]. The usual induction dose for RSII is 2 mg/kg, with reduced doses for patients at increased risk of hypotension [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H1078269073"><span class="h3">Etomidate</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">Etomidate</a> is an imidazole drug that acts directly on the gamma-aminobutyric acid<sub>A</sub> (GABA<sub>A</sub>)<sub> </sub>receptor complex, with a fast onset and short duration of action. Unlike <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>, etomidate does not cause vasodilation or myocardial depression, an advantage for patients who are at increased risk for hypotension [<a href="#rid67">67</a>]. For RSII, the induction dose of etomidate is 0.2 to 0.4 mg/kg IV, with rapid onset (30 to 45 seconds) and duration of action of 5 to 15 minutes [<a href="#rid68">68</a>]. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Etomidate'</a>.)</p><p><a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">Etomidate</a> has been associated with adrenal suppression in the first 12 hours after a single dose and may prevent a rise in cortisol in response to a surgical stimulus [<a href="#rid67">67</a>]. However, a systematic review including six trials (772 patients) reported that a single induction dose of etomidate for endotracheal intubation in critically ill patients was not associated with increased mortality compared with other induction agents [<a href="#rid69">69</a>].</p><p class="headingAnchor" id="H1078269079"><span class="h3">Ketamine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">Ketamine</a> is an NMDA receptor antagonist used for induction of anesthesia. It is a mild direct myocardial depressant [<a href="#rid70">70</a>], but in patients with an intact autonomic nervous system, it increases sympathetic tone, resulting in an increase in blood pressure, heart rate, and cardiac output [<a href="#rid71">71</a>]. Thus, ketamine is an alternative to <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> for patients at risk for hypotension. However, sympathetic stimulation with administration of ketamine is dependent upon the presence of adequate sympathetic reserve. In the patient who has maximally activated the sympathetic response and depleted all reserve (eg, patients with profound hypovolemic shock), ketamine administration may result in hypotension as a result of myocardial depression. The RSII induction dose of ketamine is 1 to 2 mg/kg IV. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Ketamine'</a>.)</p><p>Induction with <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> for patients with traumatic brain injury is controversial. The concern is that ketamine may increase cerebral blood flow and intracranial pressure (ICP), thereby reducing cerebral perfusion. However, since it increases cardiac output and maintains mean arterial pressure, cerebral perfusion may actually increase. We believe that ketamine is an appropriate induction agent for RSII in patients with suspected ICP elevation and normal blood pressure or hypotension. In patients with hypertension and suspected ICP elevation, ketamine should be <strong>avoided</strong> because of its tendency to further elevate blood pressure.</p><p class="headingAnchor" id="H107498298"><span class="h3">Barbiturates</span><span class="headingEndMark"> — </span>Prior to the introduction of <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>, thiopental was the most commonly used agent for both routine induction of anesthesia and RSII. It is no longer available in the United States, though it is still used in other parts of the world. <a class="drug drug_general" data-topicid="9629" href="/d/drug information/9629.html" rel="external">Methohexital</a> is another barbiturate used for induction, with limited availability in the United States. With an induction dose of thiopental, 3 to 5 mg/kg IV, the time to effect is less than 30 seconds, and the duration of action is approximately 5 to 10 minutes. The induction dose of methohexital is 1 to 3 mg/kg IV, with similar time to effect and duration of action [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Methohexital'</a>.)</p><p>Both barbiturates are myocardial depressants and venodilators, and can cause hypotension. Doses should be reduced for older patients and for those at risk for hypotension. In addition, thiopental releases histamine and should be avoided in patients with asthma or reactive airway disease [<a href="#rid73">73</a>].</p><p class="headingAnchor" id="H107497842"><span class="h2">Opioids</span><span class="headingEndMark"> — </span>Short-acting opioids (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> 1 to 3 mcg/kg IV three minutes prior to induction) is usually administered to reduce the sympathetic nervous system response to intubation. <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">Remifentanil</a>, an ultrashort-acting opioid, can be administered to profoundly suppress airway reflexes for intubation when the administration of NMBA is undesirable or contraindicated. (See <a class="local">'Remifentanil intubation'</a> below and  <a class="medical medical_review" href="/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview", section on 'Induction with endotracheal intubation'</a>.)</p><p class="headingAnchor" id="H107498018"><span class="h2">Lidocaine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">Lidocaine</a> (eg, 1 to 1.5 mg/kg IV given two minutes prior to intubation) is administered to blunt the sympathetic response to laryngoscopy and suppress the cough reflex [<a href="#rid74">74-77</a>]. Lidocaine pretreatment may prevent or decrease the transient rise in intracranial pressure with laryngoscopy and intubation, though studies of this effect have reached contradictory conclusions. Hypotension may occur with administration of higher doses of intravenous lidocaine [<a href="#rid78">78</a>]. (See  <a class="medical medical_review" href="/d/html/282.html" rel="external">"Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Lidocaine'</a> and  <a class="medical medical_review" href="/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview", section on 'Induction with endotracheal intubation'</a>.)</p><p class="headingAnchor" id="H1078269091"><span class="h2">Neuromuscular blocking agents (NMBAs)</span><span class="headingEndMark"> — </span>NMBAs are administered for RSII to achieve optimal intubating conditions and to prevent coughing, gagging, straining, and vomiting as a result of airway manipulation.</p><p class="headingAnchor" id="H107498340"><span class="h3">Succinylcholine</span><span class="headingEndMark"> — </span>Unless contraindicated, for most cases we suggest the use of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> (1 to 1.5 mg/kg) rather than nondepolarizing NMBAs for RSII because it provides excellent intubating conditions within 30 to 60 seconds [<a href="#rid79">79</a>]. Paralysis is achieved once fasciculations have stopped, at which point intubation can be performed. If a defasciculating dose of a nondepolarizing NMBA is administered in addition, the dose of succinylcholine must be increased to 1.5 to 2 mg/kg IV to overcome the antagonism between nondepolarizing and depolarizing NMBAs. (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Drug interactions'</a>.)</p><p><a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">Succinylcholine</a> causes muscle fasciculations in most patients, which tend to be more severe in younger and more muscular patients. Administration of succinylcholine can increase intragastric pressure, primarily as a result of fasciculation of abdominal musculature, though this effect is variable [<a href="#rid80">80</a>]. A study of thiopental/succinylcholine induction in young, unpremedicated male patients reported increases in intragastric pressure as high as 30 cmH<sub>2</sub>O over baseline. The increase was prevented by administration of a defasciculating dose of nondepolarizing NMBA (eg, <a class="drug drug_general" data-topicid="10041" href="/d/drug information/10041.html" rel="external">vecuronium</a>, <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a>, <a class="drug drug_general" data-topicid="9270" href="/d/drug information/9270.html" rel="external">cisatracurium</a>). The potential increase in intragastric pressure may be of particular concern in patients with reduced competence of the lower esophageal sphincter, such as those with abdominal distention, hiatal hernia, pregnancy, and gastroesophageal reflux. (See <a class="local">'Defasciculation'</a> below.)</p><p>When masseter muscle spasm occurs after <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a>, administration of a nondepolarizing NMDA may or may not successfully resolve the spasm [<a href="#rid81">81</a>]. If endotracheal intubation is not possible, mask ventilation should be attempted, and preparations for a surgical airway should be made. Rarely, masseter muscle spasm progresses to spasm in extremities and may herald malignant hyperthermia. Isolated masseter spasm usually resolves over approximately 20 minutes [<a href="#rid82">82</a>]. Succinylcholine is discussed more fully separately. (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Succinylcholine'</a>.)</p><p class="headingAnchor" id="H107498346"><span class="h3">Defasciculation</span><span class="headingEndMark"> — </span>We do not routinely administer a defasciculating dose of nondepolarizing NMBA before <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a>, though other clinicians do. A small dose of nondepolarizing NMBA has been shown to reduce the fasciculations, myalgias, and the increase in intragastric pressure that result from administration of succinylcholine [<a href="#rid80">80,83</a>]. The defasciculating dose should be 10 percent of the ED<sub>95</sub> for the chosen drug (ie, 2 mg <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> IV, 1.5 mg <a class="drug drug_general" data-topicid="9270" href="/d/drug information/9270.html" rel="external">cisatracurium</a> IV, or 0.3 mg <a class="drug drug_general" data-topicid="10041" href="/d/drug information/10041.html" rel="external">vecuronium</a> IV) given two to three minutes prior to induction. (The ED<sub>95</sub> is the median dose of NMBA which results in 95 percent twitch depression, and is typically much lower than the intubating dose)  (<a class="graphic graphic_table graphicRef114271" href="/d/graphic/114271.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Endotracheal intubation'</a>.)</p><p>Higher doses may result in signs of paralysis, including diplopia and difficulty breathing or swallowing, and should be avoided. If a defasciculating dose is administered, the dose of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> must be increased to 1.5 to 2 mg/kg IV to overcome the antagonism between nondepolarizing and depolarizing NMBAs [<a href="#rid84">84</a>]. Without fasciculations as a marker for paralysis, a peripheral nerve stimulator may be used to confirm adequate relaxation for intubation.</p><p>A number of other drugs have been studied as pretreatment to prevent fasciculations and myalgias, with variable results. A meta-analysis of randomized trials concluded that succinylcholine-induced fasciculations are best prevented with pretreatment with NMBAs, <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>, or magnesium [<a href="#rid83">83</a>].</p><p class="headingAnchor" id="H107498353"><span class="h3">Alternatives to succinylcholine</span></p><p class="headingAnchor" id="H714699616"><span class="h4">Nondepolarizing NMBAs</span><span class="headingEndMark"> — </span>All nondepolarizing NMBAs have a slower time to onset and longer duration of action than <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a>. When the use of succinylcholine is contraindicated, high doses of nondepolarizing NMBA can be administered to speed the onset of paralysis. However, the clinical duration of paralysis will be much longer with the use of these higher doses. This may be problematic when shorter surgery is planned or when nerve monitoring will be used during surgery. In addition, if airway management proves difficult, prolonged paralysis eliminates the option of awakening the patient to allow spontaneous ventilation.</p><p>If <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> or <a class="drug drug_general" data-topicid="10041" href="/d/drug information/10041.html" rel="external">vecuronium</a> is used for RSII, even high doses can be reversed relatively quickly with <a class="drug drug_general" data-topicid="105866" href="/d/drug information/105866.html" rel="external">sugammadex</a>. Importantly, sugammadex may not reverse the effects of muscle relaxation quickly enough to consider it a "rescue" medication in the cannot intubate, cannot ventilate scenario, especially in the setting of other depressant medications [<a href="#rid85">85</a>]. Sugammadex is discussed more fully separately. (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Sugammadex'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rocuronium</strong> – When administered for RSII, <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> is the nondepolarizing NMBA that allows the fastest onset of action and the best intubating conditions, with the least side effects. A relatively high dose of rocuronium is required for RSII. In a meta-analysis of 50 trials that compared the use of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> with rocuronium for RSII, succinylcholine &gt;1mg/kg IV provided superior intubating conditions compared with rocuronium 0.6 to 0.7 mg/kg IV, but there was no difference in intubating conditions when rocuronium 0.9 to 1.0 mg/kg IV was administered [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent1">The onset and duration of neuromuscular block depends on the dose. After induction of anesthesia with thiopental, <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> 0.9 to 1.2 mg/kg IV achieves maximal neuromuscular block in 55 to 75 seconds, with clinical duration (recovery of twitch to 25 percent of control) of 53 to 73 minutes [<a href="#rid87">87</a>]. In contrast, <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> 1.5 mg/kg IV achieves maximal block in 45 to 60 seconds, with a clinical duration of 6 to 10 minutes [<a href="#rid88">88</a>].)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Others </strong>–<strong> </strong>While less desirable than <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a>, <a class="drug drug_general" data-topicid="9270" href="/d/drug information/9270.html" rel="external">cisatracurium</a> and <a class="drug drug_general" data-topicid="10041" href="/d/drug information/10041.html" rel="external">vecuronium</a> are two other commonly used nondepolarizing NMBAs that can be used for RSII. As compared with rocuronium, the onset of paralysis with each of these is slower. Rapid onset of paralysis can be achieved by administration of a high dose, which results in prolonged duration of action, or by using a priming dose, that is, a small dose (10 percent of the intubating dose), of NMBA two to four minutes prior to the intubating dose of the drug.</p><p></p><p class="bulletIndent1">Since the priming dose of NMBA may cause signs of paralysis, including diplopia, blurry vision, difficulty swallowing, and risk of aspiration [<a href="#rid89">89</a>], we do not routinely administer a priming dose of NMBA. Recommended doses of <a class="drug drug_general" data-topicid="10041" href="/d/drug information/10041.html" rel="external">vecuronium</a> and <a class="drug drug_general" data-topicid="9270" href="/d/drug information/9270.html" rel="external">cisatracurium</a> for RSII are as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vecuronium</strong> – 0.1 mg/kg IV (approximately 2 x ED<sub>95</sub>) results in a time to maximum block of 2.4 minutes with a clinical duration (recovery of twitch to 25 percent of control) of 44 minutes [<a href="#rid90">90</a>]. In one study, a <a class="drug drug_general" data-topicid="10041" href="/d/drug information/10041.html" rel="external">vecuronium</a> dose of 0.2 mg/kg (4 x ED<sub>95</sub>) resulted in peak effect in 120 ± 17 seconds and time to recovery of 25 percent of control twitch height of 68 ± 8 minutes [<a href="#rid91">91</a>]. Like <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a>, vecuronium can be reversed with <a class="drug drug_general" data-topicid="105866" href="/d/drug information/105866.html" rel="external">sugammadex</a>.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cisatracurium</strong><strong> </strong>– 0.4 mg/kg IV (approximately 8 x ED<sub>95</sub>) results in a time to maximum block of 1.9 minutes with a clinical duration (recovery of twitch to 25 percent of control) of 91 minutes [<a href="#rid92">92</a>].</p><p></p><p class="bulletIndent1">If a nondepolarizing NMBA is used (instead of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> or for defasciculation), fasciculations do not occur as a marker of paralysis. A peripheral nerve stimulator can be used to confirm adequate paralysis and optimum intubating conditions prior to laryngoscopy. (See <a class="local">'Succinylcholine'</a> above.)</p><p></p><p class="headingAnchor" id="H107498333"><span class="h4">Remifentanil intubation</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">Remifentanil</a> is an ultrashort-acting opioid that can be used for RSII as an alternative to <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a>. A high-dose remifentanil intubation may be useful for intubation when the prolonged duration of action of nondepolarizing NMBAs is undesirable, and <a class="drug drug_general" data-topicid="105866" href="/d/drug information/105866.html" rel="external">sugammadex</a> is unavailable. A high-dose remifentanil intubation involves administration of <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> (2 to 2.5 mg/kg IV) followed by remifentanil (3 to 5 mcg/kg IV) [<a href="#rid93">93-95</a>]. We give <a class="drug drug_general" data-topicid="9114" href="/d/drug information/9114.html" rel="external">ephedrine</a> (10 mg IV) along with the propofol for this type of induction to avoid the profound bradycardia and hypotension that may result from these doses of remifentanil and propofol. Propofol 2 mg/kg IV has been shown to provide better intubating conditions than thiopental 6 mg/kg IV or <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> 0.3 mg/kg IV when given for induction with remifentanil 3 mcg/kg IV without NMBAs [<a href="#rid96">96</a>].</p><p>Observational studies have found high success rates with <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> intubation using the doses described above [<a href="#rid93">93-95</a>]. In a randomized trial that compared intubation with a hypnotic (<a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> in almost all cases) along with remifentanil 3 to 4 mcg/kg IV versus an NMBA (<a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> 1 mg/kg IV or <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> 1 mg/kg IV), successful first attempt at intubation was higher when an NMBA was administered (93.5 versus 88.5 percent, adjusted difference 4.9 percent, 95% CI 1.6-8.2 percent) [<a href="#rid97">97</a>].</p><p>Doses of <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> and <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> should be reduced for the elderly and for other patients who are at risk for hypotension with induction. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Dosing considerations'</a>.)</p><p class="headingAnchor" id="H62623"><span class="h1">MASK VENTILATION</span><span class="headingEndMark"> — </span>Ventilation by mask is traditionally not performed prior to intubation during RSII, to avoid inflating the stomach and thereby increasing the chance of regurgitation. Without the application of cricoid pressure, bag-mask ventilation with inflation pressure over 20 cmH<sub>2</sub>O can result in inflation and, potentially, distention of the stomach [<a href="#rid51">51</a>]. However, a number of studies have shown that cricoid pressure prevents gastric insufflation during mask ventilation in children and adults without airway obstruction and, in adults, with airway pressures up to 60 cmH<sub>2</sub>O [<a href="#rid49">49-51</a>].</p><p>Patients without decreased oxygen reserve or increased oxygen consumption should not desaturate during RSII without mask ventilation. For patients expected to desaturate rapidly with apnea (eg, those with decreased functional residual capacity because of obesity or increased intraabdominal pressure; those with sepsis or fever), gentle, low-pressure mask ventilation with cricoid pressure is not likely to inflate or distend the stomach.</p><p class="headingAnchor" id="H714699891"><span class="h2">Modified RSII</span><span class="headingEndMark"> — </span>There is no standard definition of "modified RSII," but most commonly it refers to the combination of cricoid pressure and mask ventilation during induction and intubation [<a href="#rid98">98</a>]. The modification of RSII may be either the addition of mask ventilation to an otherwise traditional RSII, or the application of cricoid pressure to a routine induction and intubation. Common scenarios in which modified RSII may be chosen include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>When airway evaluation suggests that intubation may be difficult for a patient who is at high risk of aspiration, gentle mask ventilation may be attempted prior to administration of a neuromuscular blocking agent (NMBA) to prove that ventilation will be possible if intubation is difficult or prolonged. In this situation, one very low-pressure breath may be all that is required.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mask ventilation may be performed for patients who are likely to desaturate with apnea, despite preoxygenation. In this situation, several low-pressure breaths (&lt;20 cmH<sub>2</sub>O) may be required while waiting for paralysis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For the patient who may be at unclear but potentially higher risk of regurgitation and aspiration, cricoid pressure may be applied during routine induction. Examples include patients with asymptomatic hiatal hernia, morbid obesity without symptoms of gastroesophageal reflux disease, and patients who have fasted appropriately but who are receiving opioids.</p><p></p><p class="headingAnchor" id="H1078269109"><span class="h1">CHOICE OF LARYNGOSCOPE</span><span class="headingEndMark"> — </span>As the goal of RSII is to intubate as rapidly as possible, the anesthesia clinician should use the laryngoscope and blade most likely to succeed on the first attempt. In most cases, this will be a standard laryngoscope used for direct laryngoscopy with a Macintosh or miller blade. However, when a difficult airway is expected, a video laryngoscope may be a better choice, assuming the clinician is facile with its use. (See  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia", section on 'Prediction of the difficult airway'</a> and  <a class="medical medical_review" href="/d/html/107795.html" rel="external">"Video laryngoscopes and optical stylets for airway management for anesthesia in adults", section on 'VL versus DL'</a>.)</p><p>No matter which laryngoscope is chosen for RSII, a backup plan and the necessary equipment must be immediately available and at the bedside if difficult airway management is expected. All anesthesia clinicians should be familiar with a difficult airway algorithm  (<a class="graphic graphic_algorithm graphicRef134460" href="/d/graphic/134460.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia", section on 'Preparation for induction of anesthesia'</a>.)</p><p>For RSII, we place a stylette in the endotracheal tube to add rigidity, to facilitate placement through the vocal cords, and to increase the chance of success on the first attempt at laryngoscopy. It is important to recognize that increasing the rigidity of the endotracheal tube can also potentially increase the risk of injury to the vocal cords or trachea. Once the tip of the tube is placed through the vocal cords, the stylette should be removed to avoid trauma to the anterior trachea and the tube advanced under direct vision.</p><p class="headingAnchor" id="H1078269121"><span class="h1">POTENTIAL COMPLICATIONS OF RSII</span><span class="headingEndMark"> — </span>The decision to perform RSII, to modify the induction sequence, or to perform a standard sequence induction must take into account the individualized potential risks of each choice. Potential complications of RSII include difficulty with intubation, hypoxia, hypotension, active regurgitation, and aspiration.</p><p class="headingAnchor" id="H64653448"><span class="h2">Difficult or failed airway</span><span class="headingEndMark"> — </span>Difficult intubation is always a possibility during induction of anesthesia. If the preoperative airway evaluation suggests potential difficulty with intubation, an awake or, if necessary, inhalation induction may be chosen instead of RSII. Difficult intubation is not always predictable [<a href="#rid99">99</a>]. Thus, equipment, personnel, and a backup plan for airway management must always be ready when RSII is performed. Anesthesia clinicians should be familiar with a difficult airway algorithm  (<a class="graphic graphic_algorithm graphicRef134460" href="/d/graphic/134460.html" rel="external">algorithm 1</a> and <a class="graphic graphic_figure graphicRef135096" href="/d/graphic/135096.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults"</a> and  <a class="medical medical_review" href="/d/html/131319.html" rel="external">"Management of the failed airway during anesthesia"</a>.)</p><p class="headingAnchor" id="H1078269128"><span class="h2">Hypoxia</span><span class="headingEndMark"> — </span>The most common risk of RSII is hypoxia, a potential result of oxygen desaturation during the period of apnea prior to intubation. Patients with poor oxygen reserves, such as obese patients, pregnant patients, and patients with pulmonary disease, may be at higher risk for arterial desaturation, despite preoxygenation. Low-pressure mask ventilation during RSII may prevent hypoxia and desaturation for such patients. (See <a class="local">'Modified RSII'</a> above.)</p><p>Passive apneic oxygenation using high-flow oxygen through a nasal cannula and continuous positive airway pressure preoxygenation are strategies that may increase the time to apneic oxygen desaturation during RSII. (See <a class="local">'Preoxygenation'</a> above.)</p><p class="headingAnchor" id="H1078269140"><span class="h2">Hypotension</span><span class="headingEndMark"> — </span>Hypotension is common after RSII, especially for those patients who present for emergency surgery with hemodynamic instability. Dysrhythmias and cardiac arrest can also occur in critically ill patients with poor cardiovascular reserve. The selection of induction agent, rate of administration, and the dose administered should be based on the patient's clinical condition and comorbidities. (See <a class="local">'Induction agents'</a> above.)</p><p class="headingAnchor" id="H4228797384"><span class="h2">Regurgitation</span><span class="headingEndMark"> — </span>Regurgitation may occur during RSII, despite the maneuvers designed to prevent it. If the patient regurgitates, the head of the operating table should be quickly tipped down to allow material to drain away from the larynx. The head should be turned to the side and the oropharynx suctioned prior to intubation. The trachea should be suctioned prior to administration of a positive pressure breath. If active vomiting occurs, cricoid pressure should be released to avoid esophageal rupture [<a href="#rid100">100</a>].</p><p class="headingAnchor" id="H64653784"><span class="h2">Aspiration</span><span class="headingEndMark"> — </span>Regurgitation and aspiration can occur during RSII, even when protocols are followed as suggested. The incidence of aspiration during emergency surgical procedures is approximately 0.15 percent [<a href="#rid101">101</a>].</p><p>The sequelae depend on the volume and type of material aspirated and the patient's comorbidities. Aspiration of small amounts of oral secretions may result in minor complications, such as cough or tracheal irritation, while aspiration of large-volume, particulate, or acidic material can result in infection, airway obstruction, acute respiratory distress syndrome, and death. Evaluation and management of aspiration pneumonia is discussed more fully separately. (See  <a class="medical medical_review" href="/d/html/7024.html" rel="external">"Aspiration pneumonia in adults"</a>.)</p><p class="headingAnchor" id="H64654216"><span class="h1">EMERGENCE FROM ANESTHESIA</span><span class="headingEndMark"> — </span>Patients at high risk of aspiration during induction of anesthesia are also at high risk of aspiration during emergence from anesthesia. In most cases, an orogastric tube should be passed during the anesthetic and suctioned and removed immediately prior to emergence. Patients should remain intubated with the endotracheal tube cuff inflated until responding to commands and until airway reflexes return. Patients should be transported to the recovery area with the head of the bed elevated to reduce the chance of reflux.</p><p class="headingAnchor" id="H823481738"><span class="h1">AIRWAY MANAGEMENT FOR PATIENTS WITH COVID-19</span><span class="headingEndMark"> — </span>In patients with COVID-19 there may be a high risk of spread of the virus during laryngoscopy and other airway management procedures. Techniques for improving patient care and minimizing infectious risks to care providers and spread of the virus during emergency intubation are summarized in the following table. Other aspects of airway management in patients with COVID-19 are discussed separately. (See  <a class="medical medical_review" href="/d/html/140910.html" rel="external">"Overview of infection control during anesthetic care", section on 'Infectious agents transmitted by aerosol (eg, COVID-19)'</a>.)</p><p class="headingAnchor" id="H4276338453"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/127884.html" rel="external">"Society guideline links: Airway management in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/126613.html" rel="external">"Society guideline links: COVID-19 – Index of guideline topics"</a>.)</p><p class="headingAnchor" id="H1078269158"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – Rapid sequence induction and intubation (RSII) is routinely performed for patients at high risk of aspiration during the induction of general anesthesia. The risk of aspiration should be balanced against the risk of difficult intubation, hypoxia during apnea, and hypotension with RSII. (See <a class="local">'General indications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preparation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients who are at high risk of aspiration, we suggest the administration of antacid medication before induction to increase the pH of gastric contents (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). For pregnant patients and for those at high risk of aspiration, we routinely administer clear, nonparticulate antacid prior to induction (eg, <a class="drug drug_general" data-topicid="9930" href="/d/drug information/9930.html" rel="external">sodium citrate-citric acid</a>, 30 mL by mouth). For nonpregnant patients at high risk of aspiration who have not received a proton pump inhibitor or histamine-2 receptor antagonist (H2RA) on the morning of surgery, we also administer an H2RA 40 to 60 minutes prior to induction (eg, <a class="drug drug_general" data-topicid="8436" href="/d/drug information/8436.html" rel="external">famotidine</a> 20 mg IV). (See <a class="local">'Premedication'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An assistant who is familiar with correct application of cricoid pressure and with assistance with airway management should be present for RSII. A back-up plan for airway management should be determined prior to induction, and the anesthesia clinician should be familiar with a difficult airway management algorithm  (<a class="graphic graphic_algorithm graphicRef134460" href="/d/graphic/134460.html" rel="external">algorithm 1</a>). (See <a class="local">'Cricoid pressure during RSII'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Goals and components of RSII</strong> – An essential goal of RSII is to achieve adequate depth of anesthesia and, most often, paralysis for laryngoscopy, to prevent coughing, straining, and active vomiting with airway manipulation.</p><p></p><p class="bulletIndent1">Components of RSII are designed to protect the airway with a cuffed endotracheal tube as quickly as possible after induction of anesthesia, while preventing passive or active regurgitation of stomach contents. They include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preoxygenation (see <a class="local">'Preoxygenation'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Application of cricoid pressure  (<a class="graphic graphic_figure graphicRef71800" href="/d/graphic/71800.html" rel="external">figure 3</a>) (see <a class="local">'Cricoid pressure during RSII'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Administration of an anesthesia induction agent, followed immediately by administration of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> (see <a class="local">'Choice of medications'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Avoidance of mask ventilation prior to endotracheal intubation (see <a class="local">'Mask ventilation'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Endotracheal intubation with inflation of the endotracheal tube cuff as quickly as possible (see <a class="local">'Choice of laryngoscope'</a> above)</p><p></p><p class="bulletIndent1">Not all of these components will be appropriate for every patient.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cricoid pressure</strong> – We suggest the application of cricoid pressure during RSII (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Despite conflicting evidence regarding the effectiveness of cricoid pressure for preventing regurgitation, clinical experience suggests that, in most situations, it is not harmful and may be beneficial. We shift or release pressure if laryngoscopy proves difficult, and release cricoid pressure if active vomiting occurs. We avoid cricoid pressure in patients with acute cervical spinal cord injury. (See <a class="local">'Cricoid pressure during RSII'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Induction of anesthesia</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We typically titrate the anesthesia induction agent to loss of consciousness prior to the administration of a neuromuscular blocking agent (NMBA). We prefer <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> for hemodynamically stable patients. <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">Ketamine</a> and <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">etomidate</a> are alternatives for hemodynamically unstable patients. (See <a class="local">'Induction agents'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most cases, we suggest the use of <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> (1 to 1.5 mg/kg) rather than nondepolarizing NMBAs for RSII (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). If a defasciculating dose of a nondepolarizing NMBA is administered in addition, the dose of succinylcholine must be increased to 1.5 to 2 mg/kg IV to overcome the antagonism between nondepolarizing and depolarizing NMBAs. (See <a class="local">'Succinylcholine'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If <a class="drug drug_general" data-topicid="9952" href="/d/drug information/9952.html" rel="external">succinylcholine</a> is contraindicated, <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a> can provide rapid onset of paralysis but results in prolonged duration of action, which may be undesirable. High-dose <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> induction is an alternative to RSII with an NMBA. (See <a class="local">'Alternatives to succinylcholine'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Modified RSII</strong> – RSII may be modified to include low-pressure mask ventilation to prove the ability to ventilate prior to paralysis or to prevent hypoxia for patients with reduced oxygen reserve. (See <a class="local">'Modified RSII'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergence from anesthesia</strong> – Patients at high risk of aspiration during induction of anesthesia are also at high risk of aspiration during emergence from anesthesia. Prior to emergence, the stomach should be emptied using an orogastric or nasogastric tube. (See <a class="local">'Emergence from anesthesia'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nishina K, Mikawa K, Takao Y, et al. A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery. Anesth Analg 2000; 90:717.</a></li><li><a class="nounderline abstract_t">Escolano F, Castaño J, López R, et al. Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery. Br J Anaesth 1992; 69:404.</a></li><li><a class="nounderline abstract_t">Puig I, Calzado S, Suárez D, et al. Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule. Pharmacol Res 2012; 65:480.</a></li><li><a class="nounderline abstract_t">Silveira SQ, da Silva LM, de Campos Vieira Abib A, et al. Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth 2023; 87:111091.</a></li><li><a class="nounderline abstract_t">Kobori T, Onishi Y, Yoshida Y, et al. Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy. J Diabetes Investig 2023; 14:767.</a></li><li><a class="nounderline abstract_t">Sherwin M, Hamburger J, Katz D, DeMaria S Jr. Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide. Can J Anaesth 2023; 70:1300.</a></li><li><a class="nounderline abstract_t">Klein SR, Hobai IA. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Can J Anaesth 2023; 70:1394.</a></li><li class="breakAll">American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists. American Society of Anesthesiologists. June 29, 2023. Available at: https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative (Accessed on July 25, 2023).</li><li><a class="nounderline abstract_t">Weber M, Siddarthan I, Mack PF. Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss. Br J Anaesth 2023; 131:e37.</a></li><li class="breakAll">Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia. Anesthesia Patient Safety Foundation. June 8, 2023. Available at: https://www.apsf.org/article/are-serious-anesthesia-risks-of-semaglutide-and-other-glp-1-agonists-under-recognized/ (Accessed on August 02, 2023).</li><li><a class="nounderline abstract_t">Dahl K, Brooks A, Almazedi F, et al. Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Diabetes Obes Metab 2021; 23:1594.</a></li><li><a class="nounderline abstract_t">Hjerpsted JB, Flint A, Brooks A, et al. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes Obes Metab 2018; 20:610.</a></li><li><a class="nounderline abstract_t">Friedrichsen M, Breitschaft A, Tadayon S, et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab 2021; 23:754.</a></li><li><a class="nounderline abstract_t">Apfelbaum JL, Hagberg CA, Connis RT, et al. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology 2022; 136:31.</a></li><li><a class="nounderline abstract_t">Stollings JL, Diedrich DA, Oyen LJ, Brown DR. Rapid-sequence intubation: a review of the process and considerations when choosing medications. Ann Pharmacother 2014; 48:62.</a></li><li><a class="nounderline abstract_t">Mort TC. Complications of emergency tracheal intubation: hemodynamic alterations--part I. J Intensive Care Med 2007; 22:157.</a></li><li><a class="nounderline abstract_t">Mort TC. The incidence and risk factors for cardiac arrest during emergency tracheal intubation: a justification for incorporating the ASA Guidelines in the remote location. J Clin Anesth 2004; 16:508.</a></li><li><a class="nounderline abstract_t">Mort TC. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts. Anesth Analg 2004; 99:607.</a></li><li><a class="nounderline abstract_t">Viegas OJ, Ravindran RS, Shumacker CA. Gastric fluid pH in patients receiving sodium citrate. Anesth Analg 1981; 60:521.</a></li><li><a class="nounderline abstract_t">Manchikanti L, Marrero TC, Roush JR. Preanesthetic cimetidine and metoclopramide for acid aspiration prophylaxis in elective surgery. Anesthesiology 1984; 61:48.</a></li><li><a class="nounderline abstract_t">St Pierre M, Krischke F, Luetcke B, Schmidt J. The influence of different patient positions during rapid induction with severe regurgitation on the volume of aspirate and time to intubation: a prospective randomised manikin simulation study. BMC Anesthesiol 2019; 19:16.</a></li><li><a class="nounderline abstract_t">Zdravkovic M, Hagberg CA, Sorbello M, Berger-Estilita J. Findings of two independent surveys on rapid sequence induction: Deliberate practice should be reinforced. Eur J Anaesthesiol 2021; 38:198.</a></li><li><a class="nounderline abstract_t">Klucka J, Kosinova M, Zacharowski K, et al. Rapid sequence induction: An international survey. Eur J Anaesthesiol 2020; 37:435.</a></li><li><a class="nounderline abstract_t">Zdravkovic M, Berger-Estilita J, Sorbello M, Hagberg CA. An international survey about rapid sequence intubation of 10,003 anaesthetists and 16 airway experts. Anaesthesia 2020; 75:313.</a></li><li><a class="nounderline abstract_t">Tanoubi I, Drolet P, Donati F. Optimizing preoxygenation in adults. Can J Anaesth 2009; 56:449.</a></li><li><a class="nounderline abstract_t">Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med 2012; 59:165.</a></li><li><a class="nounderline abstract_t">Ramachandran SK, Cosnowski A, Shanks A, Turner CR. Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration. J Clin Anesth 2010; 22:164.</a></li><li><a class="nounderline abstract_t">Taha SK, Siddik-Sayyid SM, El-Khatib MF, et al. Nasopharyngeal oxygen insufflation following pre-oxygenation using the four deep breath technique. Anaesthesia 2006; 61:427.</a></li><li><a class="nounderline abstract_t">Patel A, Nouraei SA. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia 2015; 70:323.</a></li><li><a class="nounderline abstract_t">Mir F, Patel A, Iqbal R, et al. A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia. Anaesthesia 2017; 72:439.</a></li><li><a class="nounderline abstract_t">Gander S, Frascarolo P, Suter M, et al. Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients. Anesth Analg 2005; 100:580.</a></li><li><a class="nounderline abstract_t">Delay JM, Sebbane M, Jung B, et al. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg 2008; 107:1707.</a></li><li><a class="nounderline abstract_t">Futier E, Constantin JM, Pelosi P, et al. Noninvasive ventilation and alveolar recruitment maneuver improve respiratory function during and after intubation of morbidly obese patients: a randomized controlled study. Anesthesiology 2011; 114:1354.</a></li><li><a class="nounderline abstract_t">Frerk C, Mitchell VS, McNarry AF, et al. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth 2015; 115:827.</a></li><li><a class="nounderline abstract_t">SELLICK BA. Cricoid pressure to control regurgitation of stomach contents during induction of anaesthesia. Lancet 1961; 2:404.</a></li><li><a class="nounderline abstract_t">Vanner RG, O'Dwyer JP, Pryle BJ, Reynolds F. Upper oesophageal sphincter pressure and the effect of cricoid pressure. Anaesthesia 1992; 47:95.</a></li><li><a class="nounderline abstract_t">Vanner RG, Pryle BJ. Regurgitation and oesophageal rupture with cricoid pressure: a cadaver study. Anaesthesia 1992; 47:732.</a></li><li><a class="nounderline abstract_t">Wraight WJ, Chamney AR, Howells TH. The determination of an effective cricoid pressure. Anaesthesia 1983; 38:461.</a></li><li><a class="nounderline abstract_t">Zdravkovic M, Rice MJ, Brull SJ. The Clinical Use of Cricoid Pressure: First, Do No Harm. Anesth Analg 2021; 132:261.</a></li><li><a class="nounderline abstract_t">Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015; 132:S444.</a></li><li><a class="nounderline abstract_t">Hung KC, Hung CT, Poon YY, et al. The effect of cricoid pressure on tracheal intubation in adult patients: a systematic review and meta-analysis. Can J Anaesth 2021; 68:137.</a></li><li><a class="nounderline abstract_t">Algie CM, Mahar RK, Tan HB, et al. Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation. Cochrane Database Syst Rev 2015; :CD011656.</a></li><li><a class="nounderline abstract_t">Mills P, Poole T, Curran J. Cricoid pressure and the pressor response to tracheal intubation. Anaesthesia 1988; 43:788.</a></li><li><a class="nounderline abstract_t">Birenbaum A, Hajage D, Roche S, et al. Effect of Cricoid Pressure Compared With a Sham Procedure in the Rapid Sequence Induction of Anesthesia: The IRIS Randomized Clinical Trial. JAMA Surg 2019; 154:9.</a></li><li><a class="nounderline abstract_t">Ellis DY, Harris T, Zideman D. Cricoid pressure in emergency department rapid sequence tracheal intubations: a risk-benefit analysis. Ann Emerg Med 2007; 50:653.</a></li><li><a class="nounderline abstract_t">Salem MR, Joseph NJ, Heyman HJ, et al. Cricoid compression is effective in obliterating the esophageal lumen in the presence of a nasogastric tube. Anesthesiology 1985; 63:443.</a></li><li><a class="nounderline abstract_t">Fanning GL. The efficacy of cricoid pressure in preventing regurgitation of gastric contents. Anesthesiology 1970; 32:553.</a></li><li><a class="nounderline abstract_t">Salem MR, Wong AY, Fizzotti GF. Efficacy of cricoid pressure in preventing aspiration of gastric contents in paediatric patients. Br J Anaesth 1972; 44:401.</a></li><li><a class="nounderline abstract_t">Salem MR, Wong AY, Mani M, Sellick BA. Efficacy of cricoid pressure in preventing gastric inflation during bag-mask ventilation in pediatric patients. Anesthesiology 1974; 40:96.</a></li><li><a class="nounderline abstract_t">Moynihan RJ, Brock-Utne JG, Archer JH, et al. The effect of cricoid pressure on preventing gastric insufflation in infants and children. Anesthesiology 1993; 78:652.</a></li><li><a class="nounderline abstract_t">Lawes EG, Campbell I, Mercer D. Inflation pressure, gastric insufflation and rapid sequence induction. Br J Anaesth 1987; 59:315.</a></li><li><a class="nounderline abstract_t">Zeidan AM, Salem MR, Mazoit JX, et al. The effectiveness of cricoid pressure for occluding the esophageal entrance in anesthetized and paralyzed patients: an experimental and observational glidescope study. Anesth Analg 2014; 118:580.</a></li><li><a class="nounderline abstract_t">Neelakanta G. Cricoid pressure is effective in preventing esophageal regurgitation. Anesthesiology 2003; 99:242.</a></li><li><a class="nounderline abstract_t">Smith KJ, Ladak S, Choi PT, Dobranowski J. The cricoid cartilage and the esophagus are not aligned in close to half of adult patients. Can J Anaesth 2002; 49:503.</a></li><li><a class="nounderline abstract_t">Smith KJ, Dobranowski J, Yip G, et al. Cricoid pressure displaces the esophagus: an observational study using magnetic resonance imaging. Anesthesiology 2003; 99:60.</a></li><li><a class="nounderline abstract_t">Rice MJ, Mancuso AA, Gibbs C, et al. Cricoid pressure results in compression of the postcricoid hypopharynx: the esophageal position is irrelevant. Anesth Analg 2009; 109:1546.</a></li><li><a class="nounderline abstract_t">Tournadre JP, Chassard D, Berrada KR, Boulétreau P. Cricoid cartilage pressure decreases lower esophageal sphincter tone. Anesthesiology 1997; 86:7.</a></li><li><a class="nounderline abstract_t">Skinner HJ, Bedforth NM, Girling KJ, Mahajan RP. Effect of cricoid pressure on gastro-oesophageal reflux in awake subjects. Anaesthesia 1999; 54:798.</a></li><li><a class="nounderline abstract_t">Harris T, Ellis DY, Foster L, Lockey D. Cricoid pressure and laryngeal manipulation in 402 pre-hospital emergency anaesthetics: essential safety measure or a hindrance to rapid safe intubation? Resuscitation 2010; 81:810.</a></li><li><a class="nounderline abstract_t">El-Orbany M, Connolly LA. Rapid sequence induction and intubation: current controversy. Anesth Analg 2010; 110:1318.</a></li><li><a class="nounderline abstract_t">Vanner RG, Clarke P, Moore WJ, Raftery S. The effect of cricoid pressure and neck support on the view at laryngoscopy. Anaesthesia 1997; 52:896.</a></li><li><a class="nounderline abstract_t">Haslam N, Parker L, Duggan JE. Effect of cricoid pressure on the view at laryngoscopy. Anaesthesia 2005; 60:41.</a></li><li><a class="nounderline abstract_t">Effect of Cricoid Pressure Compared With a Sham Procedure in the Rapid Sequence INduction of Anesthesia. JAMA Surg 2018.</a></li><li><a class="nounderline abstract_t">Manning BJ, Winter DC, McGreal G, et al. Nasogastric intubation causes gastroesophageal reflux in patients undergoing elective laparotomy. Surgery 2001; 130:788.</a></li><li><a class="nounderline abstract_t">Langley MS, Heel RC. Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic. Drugs 1988; 35:334.</a></li><li><a class="nounderline abstract_t">Scheffer GJ, Ten Voorde BJ, Karemaker JM, et al. Effects of thiopentone, etomidate and propofol on beat-to-beat cardiovascular signals in man. Anaesthesia 1993; 48:849.</a></li><li><a class="nounderline abstract_t">Schenarts CL, Burton JH, Riker RR. Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med 2001; 8:1.</a></li><li><a class="nounderline abstract_t">Cherfan AJ, Arabi YM, Al-Dorzi HM, Kenny LP. Advantages and disadvantages of etomidate use for intubation of patients with sepsis. Pharmacotherapy 2012; 32:475.</a></li><li><a class="nounderline abstract_t">Bruder EA, Ball IM, Ridi S, et al. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev 2015; 1:CD010225.</a></li><li><a class="nounderline abstract_t">Pagel PS, Kampine JP, Schmeling WT, Warltier DC. Ketamine depresses myocardial contractility as evaluated by the preload recruitable stroke work relationship in chronically instrumented dogs with autonomic nervous system blockade. Anesthesiology 1992; 76:564.</a></li><li><a class="nounderline abstract_t">Tweed WA, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology 1972; 37:613.</a></li><li><a class="nounderline abstract_t">Russo H, Bressolle F. Pharmacodynamics and pharmacokinetics of thiopental. Clin Pharmacokinet 1998; 35:95.</a></li><li><a class="nounderline abstract_t">Eames WO, Rooke GA, Wu RS, Bishop MJ. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology 1996; 84:1307.</a></li><li><a class="nounderline abstract_t">Aouad MT, Sayyid SS, Zalaket MI, Baraka AS. Intravenous lidocaine as adjuvant to sevoflurane anesthesia for endotracheal intubation in children. Anesth Analg 2003; 96:1325.</a></li><li><a class="nounderline abstract_t">Davidson JA, Gillespie JA. Tracheal intubation after induction of anaesthesia with propofol, alfentanil and i.v. lignocaine. Br J Anaesth 1993; 70:163.</a></li><li><a class="nounderline abstract_t">Jakobsen CJ, Ahlburg P, Holdgård HO, et al. Comparison of intravenous and topical lidocaine as a suppressant of coughing after bronchoscopy during general anesthesia. Acta Anaesthesiol Scand 1991; 35:238.</a></li><li><a class="nounderline abstract_t">Yukioka H, Hayashi M, Terai T, Fujimori M. Intravenous lidocaine as a suppressant of coughing during tracheal intubation in elderly patients. Anesth Analg 1993; 77:309.</a></li><li><a class="nounderline abstract_t">Grover VK, Reddy GM, Kak VK, Singh S. Intracranial pressure changes with different doses of lignocaine under general anaesthesia. Neurol India 1999; 47:118.</a></li><li><a class="nounderline abstract_t">Perry JJ, Lee JS, Sillberg VA, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2008; :CD002788.</a></li><li><a class="nounderline abstract_t">Miller RD, Way WL. Inhibition of succinylcholine-induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocaine. Anesthesiology 1971; 34:185.</a></li><li><a class="nounderline abstract_t">Gill M, Graeme K, Guenterberg K. Masseter spasm after succinylcholine administration. J Emerg Med 2005; 29:167.</a></li><li><a class="nounderline abstract_t">Schwartz L, Rockoff MA, Koka BV. Masseter spasm with anesthesia: incidence and implications. Anesthesiology 1984; 61:772.</a></li><li><a class="nounderline abstract_t">Schreiber JU, Lysakowski C, Fuchs-Buder T, Tramèr MR. Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials. Anesthesiology 2005; 103:877.</a></li><li><a class="nounderline abstract_t">Szalados JE, Donati F, Bevan DR. Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade. Anesth Analg 1990; 71:55.</a></li><li><a class="nounderline abstract_t">Naguib M, Brewer L, LaPierre C, et al. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios. Anesth Analg 2016; 123:82.</a></li><li><a class="nounderline abstract_t">Tran, D, Newton, et al. Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review. Anaesthesia 2017; 72:765.</a></li><li><a class="nounderline abstract_t">Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 1993; 79:913.</a></li><li><a class="nounderline abstract_t">Naguib M, Samarkandi AH, El-Din ME, et al. The dose of succinylcholine required for excellent endotracheal intubating conditions. Anesth Analg 2006; 102:151.</a></li><li><a class="nounderline abstract_t">Engbaek J, Howardy-Hansen P, Ording H, Viby-Mogensen J. Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function. Acta Anaesthesiol Scand 1985; 29:117.</a></li><li><a class="nounderline abstract_t">Agoston S, Salt P, Newton D, et al. The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study. Br J Anaesth 1980; 52 Suppl 1:53S.</a></li><li><a class="nounderline abstract_t">Tullock WC, Diana P, Cook DR, et al. Neuromuscular and cardiovascular effects of high-dose vecuronium. Anesth Analg 1990; 70:86.</a></li><li><a class="nounderline abstract_t">Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995; 82:1139.</a></li><li><a class="nounderline abstract_t">Bouvet L, Stoian A, Rimmelé T, et al. Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol. Anaesthesia 2009; 64:719.</a></li><li><a class="nounderline abstract_t">Trabold F, Casetta M, Duranteau J, et al. Propofol and remifentanil for intubation without muscle relaxant: the effect of the order of injection. Acta Anaesthesiol Scand 2004; 48:35.</a></li><li><a class="nounderline abstract_t">Klemola UM, Mennander S, Saarnivaara L. Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol. Acta Anaesthesiol Scand 2000; 44:465.</a></li><li><a class="nounderline abstract_t">Erhan E, Ugur G, Gunusen I, et al. Propofol - not thiopental or etomidate - with remifentanil provides adequate intubating conditions in the absence of neuromuscular blockade. Can J Anaesth 2003; 50:108.</a></li><li><a class="nounderline abstract_t">Grillot N, Lebuffe G, Huet O, et al. Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Randomized Clinical Trial. JAMA 2023; 329:28.</a></li><li><a class="nounderline abstract_t">Ehrenfeld JM, Cassedy EA, Forbes VE, et al. Modified rapid sequence induction and intubation: a survey of United States current practice. Anesth Analg 2012; 115:95.</a></li><li><a class="nounderline abstract_t">Cook TM, MacDougall-Davis SR. Complications and failure of airway management. Br J Anaesth 2012; 109 Suppl 1:i68.</a></li><li><a class="nounderline abstract_t">Ralph SJ, Wareham CA. Rupture of the oesophagus during cricoid pressure. Anaesthesia 1991; 46:40.</a></li><li><a class="nounderline abstract_t">Neilipovitz DT, Crosby ET. No evidence for decreased incidence of aspiration after rapid sequence induction. Can J Anaesth 2007; 54:748.</a></li></ol></div><div id="topicVersionRevision">Topic 94214 Version 41.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10702463" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1419452" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22289674" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36870274" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36919944" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37466909" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36977934" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36977934" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37302962" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37302962" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33710717" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28941314" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33269530" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34762729" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24259635" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Rapid-sequence intubation: a review of the process and considerations when choosing medications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17562739" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Complications of emergency tracheal intubation: hemodynamic alterations--part I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15590254" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The incidence and risk factors for cardiac arrest during emergency tracheal intubation: a justification for incorporating the ASA Guidelines in the remote location.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15271750" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7195668" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Gastric fluid pH in patients receiving sodium citrate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6377973" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Preanesthetic cimetidine and metoclopramide for acid aspiration prophylaxis in elective surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30678655" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The influence of different patient positions during rapid induction with severe regurgitation on the volume of aspirate and time to intubation: a prospective randomised manikin simulation study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33394797" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Findings of two independent surveys on rapid sequence induction: Deliberate practice should be reinforced.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32221099" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Rapid sequence induction: An international survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31667827" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : An international survey about rapid sequence intubation of 10,003 anaesthetists and 16 airway experts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19399574" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Optimizing preoxygenation in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22050948" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Preoxygenation and prevention of desaturation during emergency airway management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20400000" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16674614" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Nasopharyngeal oxygen insufflation following pre-oxygenation using the four deep breath technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25388828" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28035669" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15673897" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18931236" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21478734" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Noninvasive ventilation and alveolar recruitment maneuver improve respiratory function during and after intubation of morbidly obese patients: a randomized controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26556848" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13749923" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cricoid pressure to control regurgitation of stomach contents during induction of anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1539807" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Upper oesophageal sphincter pressure and the effect of cricoid pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1415968" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Regurgitation and oesophageal rupture with cricoid pressure: a cadaver study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6859475" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The determination of an effective cricoid pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31397697" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The Clinical Use of Cricoid Pressure: First, Do No Harm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26472995" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33089413" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The effect of cricoid pressure on tracheal intubation in adult patients: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26578526" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3177859" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cricoid pressure and the pressor response to tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30347104" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effect of Cricoid Pressure Compared With a Sham Procedure in the Rapid Sequence Induction of Anesthesia: The IRIS Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17681642" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cricoid pressure in emergency department rapid sequence tracheal intubations: a risk-benefit analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4037405" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Cricoid compression is effective in obliterating the esophageal lumen in the presence of a nasogastric tube.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5426267" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The efficacy of cricoid pressure in preventing regurgitation of gastric contents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5032079" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Efficacy of cricoid pressure in preventing aspiration of gastric contents in paediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4589511" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Efficacy of cricoid pressure in preventing gastric inflation during bag-mask ventilation in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8466065" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The effect of cricoid pressure on preventing gastric insufflation in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3828180" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Inflation pressure, gastric insufflation and rapid sequence induction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24557105" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The effectiveness of cricoid pressure for occluding the esophageal entrance in anesthetized and paralyzed patients: an experimental and observational glidescope study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12826877" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Cricoid pressure is effective in preventing esophageal regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11983669" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The cricoid cartilage and the esophagus are not aligned in close to half of adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12826843" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cricoid pressure displaces the esophagus: an observational study using magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19843793" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cricoid pressure results in compression of the postcricoid hypopharynx: the esophageal position is irrelevant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9009934" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Cricoid cartilage pressure decreases lower esophageal sphincter tone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10460535" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Effect of cricoid pressure on gastro-oesophageal reflux in awake subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20398995" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Cricoid pressure and laryngeal manipulation in 402 pre-hospital emergency anaesthetics: essential safety measure or a hindrance to rapid safe intubation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20237045" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Rapid sequence induction and intubation: current controversy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9349075" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The effect of cricoid pressure and neck support on the view at laryngoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15601271" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effect of cricoid pressure on the view at laryngoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Effect of Cricoid Pressure Compared With a Sham Procedure in the Rapid Sequence INduction of Anesthesia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11685187" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Nasogastric intubation causes gastroesophageal reflux in patients undergoing elective laparotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3292208" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8238825" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Effects of thiopentone, etomidate and propofol on beat-to-beat cardiovascular signals in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11136139" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Adrenocortical dysfunction following etomidate induction in emergency department patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22488264" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Advantages and disadvantages of etomidate use for intubation of patients with sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25568981" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1550282" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Ketamine depresses myocardial contractility as evaluated by the preload recruitable stroke work relationship in chronically instrumented dogs with autonomic nervous system blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4652778" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Circulatory responses to ketamine anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9739479" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Pharmacodynamics and pharmacokinetics of thiopental.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8669670" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12707127" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Intravenous lidocaine as adjuvant to sevoflurane anesthesia for endotracheal intubation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8435260" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Tracheal intubation after induction of anaesthesia with propofol, alfentanil and i.v. lignocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2038931" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Comparison of intravenous and topical lidocaine as a suppressant of coughing after bronchoscopy during general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8346830" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Intravenous lidocaine as a suppressant of coughing during tracheal intubation in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10402336" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Intracranial pressure changes with different doses of lignocaine under general anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18425883" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Rocuronium versus succinylcholine for rapid sequence induction intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4250986" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Inhibition of succinylcholine-induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16029828" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Masseter spasm after succinylcholine administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6507932" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Masseter spasm with anesthesia: incidence and implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16192781" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2363529" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27140684" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7902034" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16368821" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : The dose of succinylcholine required for excellent endotracheal intubating conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2858145" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6107107" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1967516" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Neuromuscular and cardiovascular effects of high-dose vecuronium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7741288" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19624626" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14674971" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Propofol and remifentanil for intubation without muscle relaxant: the effect of the order of injection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10757583" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12560298" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Propofol - not thiopental or etomidate - with remifentanil provides adequate intubating conditions in the absence of neuromuscular blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36594947" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22025487" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Modified rapid sequence induction and intubation: a survey of United States current practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23242753" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Complications and failure of airway management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1996754" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Rupture of the oesophagus during cricoid pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17766743" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : No evidence for decreased incidence of aspiration after rapid sequence induction.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
